A5102973001- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Diet and metabolism studies
- Genetic Syndromes and Imprinting
- Parathyroid Disorders and Treatments
- Advanced Glycation End Products research
- Muscle activation and electromyography studies
- Obesity and Health Practices
- Neuroendocrine regulation and behavior
- Neuroscience and Neural Engineering
Jiangxi Mental Health Center
2019-2022
Nanchang University
2019-2022
Anhui Provincial Hospital
2017
Anhui Medical University
2017
Cognitive deficits represent a core feature of schizophrenia. Previous studies have demonstrated that plasma asymmetric dimethylarginine (ADMA) was increased in patients with schizophrenia and correlated cognitive impairments. Atypical antipsychotics can produce benefits patients. In this study, we conducted prospective observation trial to explore whether ADMA may serve as an indicator for evaluating improvements induced by atypical A total 41 acute exacerbation were enrolled 29 completed...
Objective To compare sex difference in metabolic effect of olanzapine versus aripiprazole on schizophrenia. Methods A twelve-week prospective open-label cohort study to four subgroups according first-episode schizophrenia patients' type drug usage and sex: female (n = 11), male 10), 11) for body mass index, fasting serum triglyceride, total cholesterol, high-density lipoprotein low-density glucose. Results Aripiprazole may be associated with weight gain patients low-baseline weight. have an...
Abstract Klotho is a life extension factor that has an ability to regulate the function of GluN2B-containing N-methyl-D-aspartate receptors (NMDARs), whose dysfunction in nucleus accumbens (NAc) underlies critical aspects pathophysiology major depression. Here we study functional relevance klotho pathogenesis A chronic social defeat stress paradigm, where mice are either categorized as susceptible or unsusceptible group based on their performance interaction test, was used this study. We...
Objective To assess the application value of noninvasive fluorescence spectrometry detection advanced glycation end products for fasting hyperglycemia screening among health check-up population. Methods A total 1 388 subjects were divided into two groups based on their plasma glucose level: FPG≥7.0 mmol/L group (n=85) and FPG<7.0 (n=1 303). Advanced measured by self-developed non-invasive detector (DM Scan), results shown in form AGE value. In addition, relevant indicators also...